1. Home
  2. CIGI vs BLCO Comparison

CIGI vs BLCO Comparison

Compare CIGI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIGI
  • BLCO
  • Stock Information
  • Founded
  • CIGI 1972
  • BLCO 1853
  • Country
  • CIGI Canada
  • BLCO Canada
  • Employees
  • CIGI N/A
  • BLCO N/A
  • Industry
  • CIGI
  • BLCO Ophthalmic Goods
  • Sector
  • CIGI
  • BLCO Health Care
  • Exchange
  • CIGI Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • CIGI 6.5B
  • BLCO 5.6B
  • IPO Year
  • CIGI N/A
  • BLCO 2022
  • Fundamental
  • Price
  • CIGI $120.19
  • BLCO $14.14
  • Analyst Decision
  • CIGI Buy
  • BLCO Hold
  • Analyst Count
  • CIGI 7
  • BLCO 11
  • Target Price
  • CIGI $161.14
  • BLCO $19.10
  • AVG Volume (30 Days)
  • CIGI 126.4K
  • BLCO 610.2K
  • Earning Date
  • CIGI 05-06-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • CIGI 0.25%
  • BLCO N/A
  • EPS Growth
  • CIGI 127.75
  • BLCO N/A
  • EPS
  • CIGI 3.22
  • BLCO N/A
  • Revenue
  • CIGI $4,822,024,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • CIGI $13.02
  • BLCO $6.53
  • Revenue Next Year
  • CIGI $7.16
  • BLCO $5.64
  • P/E Ratio
  • CIGI $37.77
  • BLCO N/A
  • Revenue Growth
  • CIGI 11.23
  • BLCO 15.56
  • 52 Week Low
  • CIGI $101.01
  • BLCO $13.16
  • 52 Week High
  • CIGI $156.96
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • CIGI 38.92
  • BLCO 26.70
  • Support Level
  • CIGI $121.12
  • BLCO $15.23
  • Resistance Level
  • CIGI $127.16
  • BLCO $15.77
  • Average True Range (ATR)
  • CIGI 3.37
  • BLCO 0.44
  • MACD
  • CIGI 0.30
  • BLCO -0.05
  • Stochastic Oscillator
  • CIGI 17.19
  • BLCO 11.82

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: